Optimising treatment of elderly patients with ovarian cancer: Improving their enrolment in clinical trials

Drugs and Aging

Volumn 22, Issue 2, 2005, Pages 95-100

  Villella, Jeannine ^a   Chalas, Eva ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL; PLATINUM;

AGED; AGING; CANCER INCIDENCE; CLINICAL TRIAL; COMORBIDITY; DRUG TOLERABILITY; FATALITY; FEMALE; HUMAN; LIFE EXPECTANCY; OVARY CANCER; OVARY CARCINOMA; PHYSICIAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SIDE EFFECT;

AGED; AGING; CLINICAL TRIALS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PATIENT SELECTION; RESEARCH DESIGN; RESEARCH SUBJECTS;

EID: 15944365859     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200522020-00001     Document Type: Review

References (20)

1. NCI. National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch. In: SEER Public-Use Database, (1969-2000) 2003 ed. Based on the November 2002 submission. Issued [online]. Available from URL: http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts_Figures_2003.asp [Accessed 2004 Sep 29]
2. Mirhashemi R, Nieves-Neira W, Averette HE. Gynecologic malignancies in older women. Oncology (Huntingt) 2001; 15 (5): 580-6
3. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341 (27): 2061-7
4. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21 (7): 1383-9
5. Talarico L, Chen G, Padzur R. Elderly patients in trials for drug cancer registration: a 7-year experience by the Food and Drug Administration (FDA) [abstract no. 2928]. 39th Annual Meeting of the American Society of Clinical Oncology; 2003 May 31-Jun 3; Chicago (IL). Proc Am Soc Clin Oncol 2003; 22: 728
6. DeMichele A, Putt M, Zhang Y, et al. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 2003; 97 (9): 2150-9
7. Villella JA, Chaudhry T, Pearl ML, et al. Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian cancer. Gynecol Oncol 2002; 86 (3): 316-22
8. Pearl ML, McCauley DL, Thompson J, et al. A randomized controlled trial of early oral analgesia in gynecologic oncology patients undergoing intra-abdominal surgery. Obstet Gynecol 2002; 99 (5 Pt 1): 704-8
9. Pearl ML, Valea FA, Fischer M, et al. A randomized controlled trial of postoperative nasogastric tube decompression in gynecologic oncology patients undergoing intra-abdominal surgery. Obstet Gynecol 1996; 88 (3): 399-402
10. Pearl ML, Valea FA, Fischer M, et al. A randomized controlled trial of early postoperative feeding in gynecologic oncology patients undergoing intra-abdominal surgery. Obstet Gynecol 1998; 92(1): 94-7
11. Sundararajan V, Hershman D, Grann VR, et al. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol 2002; 20 (1): 173-8
12. Hershman D, Jacobson JS, McBride R, et al. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol 2004; 94 (2): 540-9
13. Kitler ME. Clinical trials and clinical practice in the elderly: a focus on hypertension. Drugs Aging 1992; 2 (2): 86-94
14. Abernathy D. Research challenges, new drug development, preclinical and clinical trials in the aging population. Drug Saf 1990; 5 Suppl. 1: 71-4
15. Belinson JL, Jarrell MA, McClure M, et al. Serum albumin: its relationship to marrow and renal toxicity from platinum-based combination chemotherapy. Gynecol Oncol 1990; 37 (1): 93-5
16. Ceccaroni M, D'Agostino G, Ferrandina G, et al. Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study. Gynecol Oncol 2002; 85 (3): 445-50
17. Thigpen T, Brady MF, Omura GA, et al. Age as a prognostic factor in ovarian carcinoma: the Gynecologic Oncology Group experience. Cancer 1993; 71 (2 Suppl.): 606-14
18. Moore DH, Kauderer JT, Bell J, et al. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 94 (2): 368-74
19. van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community, a systematic review of the literature. Drugs Aging 2003; 20 (3): 229-40
20. German PS, Klein LE, McPhee SJ, et al. Knowledge of and compliance with drug regimens in the elderly. J Am Geriatr Soc 1982; 30 (9): 568-71